Global DNA Polymerase Market

DNA Polymerase Market Size, Share, Growth Analysis, By Type(Taq Polymerase, Pfu Polymerase, and Proprietary Enzyme Blends), By Application(Polymerase Chain Reaction, DNA Sequencing, DNA Cloning, SNP Analysis), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35H2206 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 65 | Figures: 75

DNA Polymerase Market News

  • In March 2024, Applied DNA Sciences, Inc., a biotechnology firm working in PCR-based DNA manufacturing, announced a collaboration with enzyme producer Alphazyme LLC to improve the production capacity of a critical enzyme used in mRNA therapeutics.

     

  • In December 2023, Codexis and Aldevron announced an exclusive licensing agreement for Codex® HiCap RNA Polymerase. Aldevron will gain global manufacturing and commercialization rights for the polymerase, while Codexis will get payments for near-term technical milestones, alongside commercial achievements and sales-based royalties. Both companies will collaborate to facilitate a seamless change for customers during the transitional period.

     

  • In December 2023, CCM Biosciences, a diversified biotechnology company, disclosed the establishment of its new business unit, CCM 5Prime Sciences. This unit is committed to using proprietary technology in DNA biotechnology. 5Prime's technology platform comprises several patent-protected compositions and methods globally utilized for molecular cloning, next-generation DNA sequencing, and molecular diagnostics.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

DNA Polymerase Market size was valued at USD 132.6 million in 2022 and is poised to grow from USD 134.32 million in 2023 to USD 148.95 million by 2031, at a CAGR of 1.30% during the forecast period (2024-2031).

The DNA polymerase market is characterized by intense competition among key players in the industry. The market is driven by the increasing demand for DNA polymerase in various sectors such as biotechnology, research laboratories, medical diagnostics, and forensics. The need for accurate DNA replication and amplification techniques has fueled the market growth. 'Thermo Fisher Scientific Inc. - United States', 'Merck KGaA - Germany', 'New England Biolabs - United States', 'Promega Corporation - United States', 'Agilent Technologies Inc. - United States', 'Illumina, Inc. - United States', 'QIAGEN N.V. - Netherlands', 'Takara Bio Inc. - Japan', 'Bio-Rad Laboratories, Inc. - United States', 'F. Hoffmann-La Roche Ltd. - Switzerland', 'Sigma-Aldrich Corporation (now part of Merck KGaA) - United States', 'LGC Limited - United Kingdom', 'Enzo Biochem, Inc. - United States', 'Lucigen Corporation - United States', 'Bioline GmbH (a Meridian Bioscience Company) - Germany', 'Toyobo Co., Ltd. - Japan', 'Genesee Scientific Corporation - United States', 'Vazyme Biotech Co., Ltd. - China', 'Takara Bio USA Holdings, Inc. - United States', 'Jena Bioscience GmbH - Germany'

The increasing occurrence of chronic diseases like cancer and cardiovascular disease has led to a growing requirement for diagnostic and treatment technologies. In light of this, the demand for DNA polymerase, which plays a crucial role in the amplification process of PCR, has risen significantly in the Post Covid era. The treatment of cancer, in particular, has seen a greater utilization of high-fidelity DNA polymerases. There is now a greater need for a superior DNA polymerase that can accurately replicate DNA and detect mutations with a high level of sensitivity and specificity. Consequently, there has been a development of new DNA polymerase products that possess improved fidelity, speed, and overall performance. Additionally, specialized polymerases capable of amplifying and identifying DNA sequences associated with various diseases have also been created.

Growing adoption of DNA polymerases in the field of personalized medicine and targeted therapies: As precision medicine gains prominence, DNA polymerases are being used to identify specific genetic variations and mutations associated with diseases. This enables the development of tailored treatments and therapies for individual patients, leading to improved clinical outcomes.

North America emerges as the dominant regional segment in the DNA polymerase market. The escalating prevalence of chronic diseases such as cancer, diabetes, and others has led to an increased demand for DNA polymerase in biotechnology laboratories. This polymerase is crucial for DNA replication and subsequent extension, thus driving its market growth. For instance, according to the World Health Organization (WHO), in the United States alone, there are approximately 37.3 million individuals living with diabetes, 96 million adults with prediabetes, and an estimated annual cost of $327 billion associated with diabetes. The market for DNA polymerase is expected to expand further due to the growing adoption of recombinant medications for the treatment of chronic diseases.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Polymerase Chain Reaction (PCR) Market
Buy Now GET FREE SAMPLE
DNA Synthesis Market
Buy Now GET FREE SAMPLE
Recombinant DNA Technology Market
Buy Now GET FREE SAMPLE
Nucleotide Market
Buy Now GET FREE SAMPLE
DNA Forensics Market
Buy Now GET FREE SAMPLE
Gene Editing Market
Buy Now GET FREE SAMPLE
Nucleic Acid Therapeutics Market
Buy Now GET FREE SAMPLE
Polymer Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global DNA Polymerase Market

Report ID: SQMIG35H2206

$5,300
BUY NOW GET FREE SAMPLE